Asian Institute Of Gastroenterology, India
Clinical trials sponsored by Asian Institute Of Gastroenterology, India, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could your own belly fat fix a stubborn Crohn's fistula? Results expected Oct 2026 (estimated)
- Green diagnosis: study pits EUS against MRCP to see which gallstone test has a smaller carbon footprint Results expected Nov 2026 (estimated)
- Brain scans reveal hidden pain pathways in chronic pancreatitis Results expected Nov 2026 (estimated)
- Can Water-Filled stomach surgery spare patients from scalpel? Results expected Nov 2026 (estimated)
- New acid blocker vonaprazan takes on esomeprazole in reflux healing showdown Results expected Nov 2026 (estimated)
-
Can 7 days of steroids beat 14 for Alcohol-Related liver disease?
Disease control CompletedThis phase 3 trial compares two steroid schedules for severe alcohol-associated hepatitis, a serious liver condition with high death rates. One group takes prednisolone for 7 days followed by a placebo for 7 days, while the other takes prednisolone for the full 14 days. Researche…
Phase 3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Race against time: does getting ERCP within 24 hours save lives?
Disease control CompletedThis study looked at 304 patients with mild to moderate acute cholangitis, a serious bile duct infection. Researchers compared performing ERCP (a drainage procedure) within 24 hours versus waiting 24 to 48 hours. The goal was to see if faster treatment reduces deaths within 30 da…
Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC